<VariationArchive VariationID="504196" VariationName="NM_000039.3(APOA1):c.85dup (p.Gln29fs)" VariationType="Duplication" Accession="VCV000504196" Version="9" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-05-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="495696" VariationID="504196">
      <GeneList>
        <Gene Symbol="APOA1" FullName="apolipoprotein A1" GeneID="335" HGNC_ID="HGNC:600" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="116835751" stop="116837950" display_start="116835751" display_stop="116837950" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="116706468" stop="116708337" display_start="116706468" display_stop="116708337" Strand="-" />
          </Location>
          <OMIM>107680</OMIM>
        </Gene>
        <Gene Symbol="APOA1-AS" FullName="APOA1 antisense RNA" GeneID="104326055" HGNC_ID="HGNC:40079" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="116836117" stop="116855729" display_start="116836117" display_stop="116855729" Strand="+" />
          </Location>
          <OMIM>620112</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000039.3(APOA1):c.85dup (p.Gln29fs)</Name>
      <CanonicalSPDI>NC_000011.10:116837115:GGGGGGG:GGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="116837115" stop="116837116" display_start="116837115" display_stop="116837116" variantLength="1" positionVCF="116837115" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="116707831" stop="116707832" display_start="116707831" display_stop="116707832" variantLength="1" positionVCF="116707831" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>Q29fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_767" sequenceAccession="LRG_767">
            <Expression>LRG_767:g.5507dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000039.1" sequenceAccession="NM_000039" sequenceVersion="1" change="c.85dupC">
            <Expression>NM_000039.1:c.85dupC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.116837122dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.116837122dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.116707838dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.116707838dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012021.1" sequenceAccession="NG_012021" sequenceVersion="1" change="g.5507dup">
            <Expression>NG_012021.1:g.5507dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000039.3" sequenceAccession="NM_000039" sequenceVersion="3" change="c.85dup" MANESelect="true">
            <Expression>NM_000039.3:c.85dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000030.1" sequenceAccession="NP_000030" sequenceVersion="1" change="p.Gln29fs">
            <Expression>NP_000030.1:p.Gln29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318017.2" sequenceAccession="NM_001318017" sequenceVersion="2" change="c.85dup">
            <Expression>NM_001318017.2:c.85dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001304946.1" sequenceAccession="NP_001304946" sequenceVersion="1" change="p.Gln29fs">
            <Expression>NP_001304946.1:p.Gln29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318018.2" sequenceAccession="NM_001318018" sequenceVersion="2" change="c.85dup">
            <Expression>NM_001318018.2:c.85dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001304947.1" sequenceAccession="NP_001304947" sequenceVersion="1" change="p.Gln29fs">
            <Expression>NP_001304947.1:p.Gln29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318021.1" sequenceAccession="NM_001318021" sequenceVersion="1" change="c.-240-3dup">
            <Expression>NM_001318021.1:c.-240-3dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_767t1" sequenceAccession="LRG_767t1">
            <Expression>LRG_767t1:c.79dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_767p1" sequenceAccession="LRG_767p1" change="p.Gln29Profs">
            <Expression>LRG_767p1:p.Gln29Profs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA6289899" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="107680.0018" DB="OMIM" />
        <XRef Type="rs" ID="753348565" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000039.3(APOA1):c.85dup (p.Gln29fs) AND not provided" Accession="RCV000599012" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2022-02-23" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000039.3(APOA1):c.85dup (p.Gln29fs) AND Hypoalphalipoproteinemia, primary, 2, intermediate" Accession="RCV004594084" Version="1">
        <ClassifiedConditionList TraitSetID="74488">
          <ClassifiedCondition DB="MedGen" ID="C5677030">Hypoalphalipoproteinemia, primary, 2, intermediate</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1993-10-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-23" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2013-04-04" MostRecentSubmission="2024-05-26">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">28870971</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8240372</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-11-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-11-17">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="74488" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="62352" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypoalphalipoproteinemia, primary, 2, intermediate</ElementValue>
                <XRef ID="MONDO:0859238" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="619836" DB="OMIM" />
              </Name>
              <XRef ID="C5677030" DB="MedGen" />
              <XRef ID="MONDO:0859238" DB="MONDO" />
              <XRef Type="MIM" ID="619836" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1390512" SubmissionDate="2019-01-29" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDX:1913271|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000710506" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.85dupC variant in the APOA1 gene has been reported previously in association with low HDL cholesterol and apolipoprotein A-I levels (Nakata et al., 1993; Dron et al., 2017). The c.85dupC variant causes a frameshift starting with codon Glutamine 29, changes this amino acid to a Proline residue, and creates a premature Stop codon at position 30 of the new reading frame, denoted p.Gln29ProfsX30. This variant is predicted to cause loss of normal protein function through protein truncation. The c.85dupC variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.85dupC as a likely pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="GG" referenceAllele="G" start="116707831" stop="116707832" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000039.1:c.85dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7118034" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="fe06c82b2b9e9ed14df11f4016775cd9d4fcaff896d6815dc71286f3bb7f805a|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003815545" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000039.2:c.85dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4231882" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4901110|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002209343" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8240372</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28870971</ID>
          </Citation>
          <Comment>The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This sequence change creates a premature translational stop signal (p.Gln29Profs*30) in the APOA1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 239 amino acid(s) of the APOA1 protein. This premature translational stop signal has been observed in individual(s) with clinical features of APOA1-related conditions (PMID: 8240372, 28870971). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 504196).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.116707831_116707832insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="39815" SubmissionDate="2019-08-19" DateLastUpdated="2024-05-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="107680.0018_HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, INTERMEDIATE" title="APOA1, 1-BP INS, C_HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, INTERMEDIATE" />
        <ClinVarAccession Accession="SCV000039815" DateUpdated="2024-05-26" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-10-29">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 members of a Japanese family with primary intermediate hypoalphalipoproteinemia-2 (619836), Nakata et al. (1993) identified heterozygosity for an insertion of a single C in the run of 7 cytosines between codons 3 and 5 of the mature sequence of the APOA1 gene. The variant, designated APOA1-Tsukuba, resulted in a frameshift and a premature stop at codon 34. The proband, her mother, and maternal aunt had average plasma HDL-C and apoA-I levels of 50% and 53%, respectively, of those of controls.</Attribute>
              <Citation>
                <ID Source="PubMed">8240372</ID>
              </Citation>
              <XRef DB="OMIM" ID="619836" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOA1" />
          </GeneList>
          <Name>APOA1, 1-BP INS, C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="107680.0018" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, INTERMEDIATE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39815" TraitType="Disease" MappingType="Name" MappingValue="HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, INTERMEDIATE" MappingRef="Preferred">
        <MedGen CUI="C5677030" Name="Hypoalphalipoproteinemia, primary, 2, intermediate" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4231882" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7118034" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1390512" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

